The only constant is change

And so we innovate perpetually

Since we ventured into pharmaceutical business 5 years ago, our basic strategy for growth and success has been to reinforce our core businesses viz.APIs and speciality bulk actives by continually expanding, upgrading, diversifying and innovating to develop new molecules and business reach by investing in and conducting intensive R&D backed by extensive market research for indepth understanding of the market needs.

IPR Registered
  • Application Number
  • Title/ Remarks
  • Application Number1426/MUM/2014
  • Title/ RemarksEnvironment friendly Silver Nanocomposite and method for the same
  • Application Number282/MUM/2015
  • Title/ RemarksAn improved process for the preparation of Darunavar
  • Application Number283/MUM/2015
  • Title/ RemarksAn process for the preparation of Enofovir Disoproxil Fumarate
  • Application Number284/MUM/2015
  • Title/ RemarksAn improved process for the preparation of Atazanavir
Nano Technology

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged. It was popularised in the 1960s with the release of Letraset sheets containing Lorem Ipsum passages, and more recently with desktop publishing software like Aldus PageMaker including versions of Lorem Ipsum.